ES2062125T3 - Una composicion farmaceutica que contiene derivados de hidantoina. - Google Patents

Una composicion farmaceutica que contiene derivados de hidantoina.

Info

Publication number
ES2062125T3
ES2062125T3 ES90103279T ES90103279T ES2062125T3 ES 2062125 T3 ES2062125 T3 ES 2062125T3 ES 90103279 T ES90103279 T ES 90103279T ES 90103279 T ES90103279 T ES 90103279T ES 2062125 T3 ES2062125 T3 ES 2062125T3
Authority
ES
Spain
Prior art keywords
pharmaceutical composition
composition
composition containing
hydantoin derivatives
containing hydantoin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90103279T
Other languages
English (en)
Inventor
Masayasu Kurono
Makoto Sato
Shigeaki Yoshina
Yoshiya Kondo
Tsuneaki Inoue
Akiharu Inoue
Kiichi Sawai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanwa Kagaku Kenkyusho Co Ltd
Original Assignee
Sanwa Kagaku Kenkyusho Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2026139A external-priority patent/JP2688266B2/ja
Application filed by Sanwa Kagaku Kenkyusho Co Ltd filed Critical Sanwa Kagaku Kenkyusho Co Ltd
Application granted granted Critical
Publication of ES2062125T3 publication Critical patent/ES2062125T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

SE REVELA UNA COMPOSICION FARMACEUTICA QUE MUESTRA INHIBICION A LAS ENZIMAS ALDOSA REDUCTASAS. EN DICHA COMPOSICION, EL DERIVADO DE LA HIDANTOINA CONOCIDA PER SE, ES DISPERSADO UNIFORMEMENTE EN EL PORTADOR MOLECULAR PARA EL DERIVADO DE LA HIDANTOINA. LA COMPOSICION ADEMAS PUEDE CONTENER UNA SUSTANCIA MOLECULAR SOLUBLE EN AGUA. DICHA COMPOSICION ES ADMINISTRADA PARA PREVENIR O CURAR UNA COMPLICACION DEBIDA A LA DIABETES.
ES90103279T 1989-02-22 1990-02-20 Una composicion farmaceutica que contiene derivados de hidantoina. Expired - Lifetime ES2062125T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP4274389 1989-02-22
JP5869489 1989-03-10
JP2026139A JP2688266B2 (ja) 1989-02-22 1990-02-07 アルドース還元酵素阻害作用を有し且つ吸収性の良好な薬剤組成物

Publications (1)

Publication Number Publication Date
ES2062125T3 true ES2062125T3 (es) 1994-12-16

Family

ID=27285280

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90103279T Expired - Lifetime ES2062125T3 (es) 1989-02-22 1990-02-20 Una composicion farmaceutica que contiene derivados de hidantoina.

Country Status (10)

Country Link
EP (1) EP0384416B1 (es)
AT (1) ATE96668T1 (es)
AU (1) AU627843B2 (es)
CA (1) CA2021923C (es)
DE (1) DE69004290T2 (es)
DK (1) DK0384416T3 (es)
ES (1) ES2062125T3 (es)
FI (1) FI93694C (es)
NZ (1) NZ232619A (es)
WO (1) WO1990009791A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03215435A (ja) * 1990-01-12 1991-09-20 Sanwa Kagaku Kenkyusho Co Ltd アルドース還元酵素阻害剤を主成分とする潰瘍治療剤
JPH0784481B2 (ja) * 1991-02-21 1995-09-13 株式会社デイ・デイ・エス研究所 カルボキシメチルマンノグルカン及びその誘導体
CA2349098C (en) * 2000-05-30 2011-03-01 Integrated Biomedical Technology, Inc. Assay for aldehyde content

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4181729A (en) * 1979-03-21 1980-01-01 Pfizer Inc. Phenyl or phenoxy substituted spiro-imidazolidinedione derivatives
FR2455046A1 (fr) * 1979-04-25 1980-11-21 Science Union & Cie Nouvelles hydantoines, leur procede de preparation et leur emploi comme medicament
JPS58213717A (ja) * 1982-01-20 1983-12-12 Eisai Co Ltd ヒダントイン誘導体を含有する治療用薬剤
JPS58124788A (ja) * 1982-01-20 1983-07-25 Eisai Co Ltd 光学活性ヒダントイン誘導体，その製造方法ならびにそれを含有する治療用薬剤
JPS61200991A (ja) * 1985-03-04 1986-09-05 Sanwa Kagaku Kenkyusho:Kk スピロ―３―ヘテロアゾリジン化合物、その製法及びそれを有効成分とする糖尿病合併症の予防及び治療剤
DE3769066D1 (de) * 1986-08-28 1991-05-08 Sanwa Kagaku Kenkyusho Co Hydantoin-derivate zur behandlung von komplikationen bei diabetes.
ATE52186T1 (de) * 1986-09-02 1990-05-15 Alcon Lab Inc Aldose-reductase-hemmer, nuetzlich bei der behandlung von glaukom.

Also Published As

Publication number Publication date
EP0384416B1 (en) 1993-11-03
AU5107690A (en) 1990-09-26
FI93694B (fi) 1995-02-15
ATE96668T1 (de) 1993-11-15
CA2021923A1 (en) 1990-08-23
EP0384416A1 (en) 1990-08-29
CA2021923C (en) 1998-04-28
WO1990009791A1 (en) 1990-09-07
DE69004290D1 (de) 1993-12-09
FI93694C (fi) 1995-05-26
DK0384416T3 (da) 1994-02-28
NZ232619A (en) 1992-06-25
FI905179A0 (fi) 1990-10-19
AU627843B2 (en) 1992-09-03
DE69004290T2 (de) 1994-05-26

Similar Documents

Publication Publication Date Title
DE69231457D1 (de) Zyklodextrin-Zusammensetzung enthaltend Fumagillol-Derivate
GB2014981B (en) Substituted propanolamine and morpholine derivatives
AU560179B2 (en) Hypoglycemic thiazolidinedione derivatives
SE8503680L (sv) Indolderivat
LU90283I2 (fr) Sporanox soluté buvable et ses dérivés pharmaceutiquement acceptables
NO20020758D0 (no) N<o>6</o> heterocykliske substituerte adenosinderivater
IS3156A7 (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
IE790088L (en) Thienohydantoin derivatives
FI885109A0 (fi) Foerfarande foer solidifikation och inkapsling med anvaendning av kaern-skalpolymerpartiklar.
ATE3865T1 (de) Hydantoinamine und deren pharmazeutische zusammensetzungen.
AU6889196A (en) Long active composition for rectal administration
SE8900346D0 (sv) Farmaceutisk komposition som innehaaller ett plantextrakt samt foerfarande foer framstaellning av detsamma
KR920002151A (ko) 15-케토-프로스타글란딘 화합물에 의한 염증성 질환 치료
ATE59294T1 (de) Stabilisierte arzneimittel.
ATE270114T1 (de) Zusammensetzungen und gegenstände zur verminderung der auswirkung von entzündungen
ES2062125T3 (es) Una composicion farmaceutica que contiene derivados de hidantoina.
ES2038064B1 (es) Instalacion portatil de vacunacion aviar.
KR910009270A (ko) 15-케토-프로스타글란딘 화합물을 이용한 심기능장애의 치료방법
EA199700095A1 (ru) Фармацевтическая композиция для парентерального введения, содержащая индолкарбоновую кислоту
EP0384364A3 (en) A composition of nonlinear optical materials and a method for preparing the same
DK72591A (da) Hidtil ukendt s-timolol-derivat samt fremgangsmaade til fremstilling deraf
DK89289A (da) Anvendelse af 1,4-dihydropyridin-derivater til fremstilling af laegemiddel til afvaenning af alkoholister
ES2062794T3 (es) Derivados de (alquiltio-3 propil)-3 benzotiazolina, su preparacion y los medicamentos que les contienen.
DE3762854D1 (de) Pharmazeutische zusammensetzungen mit inhalt von 5-phenyl-1,3-dioxoalkenylverbindungen.
ES2101531T3 (es) Derivados de benzo(f)quinoxalinadiona, su preparacion y su utilizacion en medicamentos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 384416

Country of ref document: ES